247 related articles for article (PubMed ID: 28272498)
1. The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.
Brzozowska NI; de Tonnerre EJ; Li KM; Wang XS; Boucher AA; Callaghan PD; Kuligowski M; Wong A; Arnold JC
Neuropsychopharmacology; 2017 Oct; 42(11):2222-2231. PubMed ID: 28272498
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice.
Kirschbaum KM; Henken S; Hiemke C; Schmitt U
Behav Brain Res; 2008 Apr; 188(2):298-303. PubMed ID: 18164477
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein interaction with risperidone and 9-OH-risperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments.
Ejsing TB; Pedersen AD; Linnet K
Hum Psychopharmacol; 2005 Oct; 20(7):493-500. PubMed ID: 16118767
[TBL] [Abstract][Full Text] [Related]
4. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Batool F; Hasnat A; Haleem MA; Haleem DJ
Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters?
Reist C; Wu JC; Lilja Y; Mukherjee J; Gripeos D; Constantinescu C; Raggi MA; Mercolini L; Ozdemir V
J Clin Psychopharmacol; 2012 Feb; 32(1):110-3. PubMed ID: 22198458
[TBL] [Abstract][Full Text] [Related]
7. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
Gogos A; Bogeski M; van den Buuse M
Behav Pharmacol; 2008 Sep; 19(5-6):548-61. PubMed ID: 18690109
[TBL] [Abstract][Full Text] [Related]
8. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Wang JS; Zhu HJ; Markowitz JS; Donovan JL; DeVane CL
Psychopharmacology (Berl); 2006 Sep; 187(4):415-23. PubMed ID: 16810505
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M
Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196
[TBL] [Abstract][Full Text] [Related]
11. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
[TBL] [Abstract][Full Text] [Related]
12. Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.
Spiro AS; Wong A; Boucher AA; Arnold JC
PLoS One; 2012; 7(4):e35937. PubMed ID: 22536451
[TBL] [Abstract][Full Text] [Related]
13. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
Seeman P; Tallerico T
Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
[TBL] [Abstract][Full Text] [Related]
14. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
Porter JH; Walentiny DM; Philibin SD; Vunck SA; Crabbe JC
Behav Pharmacol; 2008 Sep; 19(5-6):530-42. PubMed ID: 18690107
[TBL] [Abstract][Full Text] [Related]
16. In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.
Loryan I; Melander E; Svensson M; Payan M; König F; Jansson B; Hammarlund-Udenaes M
Mol Psychiatry; 2016 Nov; 21(11):1527-1536. PubMed ID: 26809840
[TBL] [Abstract][Full Text] [Related]
17. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.
Boulton DW; DeVane CL; Liston HL; Markowitz JS
Life Sci; 2002 May; 71(2):163-9. PubMed ID: 12031686
[TBL] [Abstract][Full Text] [Related]
18. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
Chernet E; Martin LJ; Li D; Need AB; Barth VN; Rash KS; Phebus LA
Life Sci; 2005 Dec; 78(4):340-6. PubMed ID: 16139310
[TBL] [Abstract][Full Text] [Related]
19. LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.
Tislerova B; Brunovsky M; Horacek J; Novak T; Kopecek M; Mohr P; Krajca V
Neuropsychobiology; 2008; 58(1):1-10. PubMed ID: 18781085
[TBL] [Abstract][Full Text] [Related]
20. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; DeVane CL
Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
